Skip to content
DataLookout
Menu

NCT07452120

DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery

StatusRecruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words
    • Study completion pushed from Nov 1, 2026 to Feb 1, 2027
    • Publications: details revised at 4 of 4 entries
  2. Notable Recruitment opened
    • Study sites: 1 to 2
    • Start date changed from estimate of Apr 1, 2026 to Mar 27, 2026
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Postoperative pain intensity
Timeframe: 2, 4, 8, 16, 24, and 48 hours postoperatively

Secondary (3)

Opioid consumption
Motor block
Pain during movement

Arms and interventions

Suprainguinal Fascia Iliaca Block (SIFIB)Experimental

Participants randomized to this arm will receive an ultrasound-guided suprainguinal fascia iliaca compartment block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Deep Iliacus Plane Block (DIPB)Experimental

Participants randomized to this arm will receive an ultrasound-guided deep iliacus plane block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Procedures: Suprainguinal Fascia Iliaca Block, Deep Iliacus Plane Block

Sites

2 sites in 1 country